SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Viz HCM
AI Verdict
Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…
Choose SensiCardiac Mobi if your clinical practice involves direct auscultation and you require AI-powered decision support to accurately differentiate between physiological and pathological heart murmurs in real-time. This tool is ideal for physicians seeking to enhance their physical examination with objective acoustic analysis at the point of care, aiding in the initial diagnosis of heart murmurs.
View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →Choose Viz HCM if…
Choose Viz HCM if your hospital or health system aims to implement an automated, system-wide screening program for Hypertrophic Cardiomyopathy (HCM) using existing ECG data. This solution is best for organizations focused on reducing HCM diagnosis time and streamlining care coordination through real-time AI alerts and automated patient routing to specialized care teams.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION | Viz HCM |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based |
| Deployment | Hosted server environment (Linux OS) with a mobile application interface | Cloud-based platform, integrated into hospital IT systems (EHR, PACS). |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM offers a cloud-based platform with seamless integration into existing hospital IT systems like EHR and PACS, along with mobile-based alerts for care teams, suggesting a highly integrated user experience. SensiCardiac Mobi, while having a mobile application with good user scores from its FDA clearance, relies on a user-provided electronic stethoscope and may be less integrated into broader clinical workflows.
Clinical Value
Viz HCMViz HCM is FDA-cleared and boasts extensive clinical validation with numerous real-world evidence and publications, demonstrating its ability to significantly reduce diagnosis time and improve patient outcomes for Hypertrophic Cardiomyopathy. SensiCardiac Mobi is also FDA-cleared as a decision support tool for heart murmur diagnosis, with its safety and effectiveness confirmed against a predicate device in its 2013 clearance.
Pricing & Value
Viz HCMViz HCM provides transparency with its subscription-based pricing model and offers significant value through CMS reimbursement for specific CPT codes, effective January 1, 2025. SensiCardiac Mobi's pricing details are not publicly available, requiring direct contact with the vendor, which offers less clarity on its value proposition.
Enterprise Readiness
Viz HCMViz HCM is designed as a cloud-based platform with seamless integration into existing hospital IT systems, including EHR and PACS, and supports multidisciplinary care team coordination. SensiCardiac Mobi operates from a hosted server environment with a mobile application interface and requires user-provided hardware, which may present more challenges for large-scale enterprise integration.
Innovation
Viz HCMBoth tools utilize AI for cardiac diagnosis. However, Viz HCM's real-time ECG analysis for Hypertrophic Cardiomyopathy detection, coupled with intelligent care coordination to significantly reduce diagnosis time and streamline workflows, represents a more advanced and comprehensive application of AI in the clinical pathway.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient comparative information regarding the specific details, quality, or comprehensiveness of customer support and documentation for either SensiCardiac Mobi or Viz HCM. Therefore, a definitive winner cannot be determined in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION | Viz HCM |
|---|---|---|
| Name | SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION | Viz HCM |
| Company | DIACOUSTIC MEDICAL DEVICES (PTY) | Viz.ai |
| Primary AI Focus | Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds. | Uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM). |
| Input Data Source | Acoustic heart signals from an electronic stethoscope (user-provided) | Real-time ECG analysis from electrocardiograms |
| Core Functionality/Output | Acquires and records acoustic heart signals; Analyzes heart sounds; Distinguishes between normal/physiological and pathological heart murmurs; Identifies S1, S2, and suspected murmurs; Operates as a decision support software. | AI-powered ECG analysis for HCM detection; Real-time disease detection; Mobile-based alerts and notifications; Automated direction of patients to appropriate care specialists; Reduces time to diagnosis and treatment for HCM. |
| System Integration | Mobile application for data capture and display (e.g., iPhone 4S or later); Requires a compatible electronic stethoscope. | Seamless integration with existing clinical workflows, EHR, and PACS systems. |
Videos
Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Viz HCM.